# Prof. Deepak Hegde's research on the impact of lobbying on NIH funding is featured

1 Faculty News November 5, 2014 ![](/sites/default/files/styles/246w/public/assets/images/nature.jpg?itok=LtGQKroy)>

Excerpt from [Nature](http://www.nature.com/news/lobbying-sways-nih-grants-1.16280) -- "Advocates for patients with rare diseases spend millions of dollars lobbying the US Congress each year — and it is money well spent, an economic analysis has found. Between 1998 and 2008, such efforts helped to increase new funding for rare-disease programmes by 3–15% each year at the US National Institutes of Health (NIH), according to a report to be published in Management Science ([D. Hegde](http://www.stern.nyu.edu/faculty/bio/deepak-hegde) and B. N. Sampat Mgmt Sci. <http://doi.org/fzs2vx>; 2014)."

[Read more](http://www.nature.com/news/lobbying-sways-nih-grants-1.16280)